Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T01:48:24.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a clinical study on the combination of savolitinib and osimertinib for treating non-small cell lung cancer, while adding a new interventional model description and a revision note.
    Difference
    40%
    Check dated 2025-04-16T14:16:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 3, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T08:55:57.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to v2.14.3, replacing the previous date of February 3, 2025, and revision v2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T23:10:24.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-02-24T20:21:37.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The webpage has updated its last update information and provided new dates for upcoming events, while also noting that some services may experience heavy traffic affecting performance and availability.
    Difference
    2%
    Check dated 2025-02-10T09:35:02.000Z thumbnail image

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.